{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT04620811: Phase 3 Interventional Completed Eosinophilic Gastritis
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02290951: Phase 1 Interventional Active, not recruiting Non-Hodgkin Lymphoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03902184: Phase 2 Interventional Active, not recruiting Lymphoma, T-Cell
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03337698: Phase 1/Phase 2 Interventional Active, not recruiting Carcinoma, Non-Small-Cell Lung
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT00244257: Phase 1 Interventional Terminated Idiopathic Thrombocytopenic Purpura
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03512340: Phase 1 Interventional Completed Advanced Solid Cancers
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03362060: Phase 1 Interventional Active, not recruiting Triple Negative Breast Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03362060: Phase 1 Interventional Active, not recruiting Triple Negative Breast Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03456830: Phase 3 Interventional Completed Enteric Hyperoxaluria
(2018)
Source URL:
Class:
PROTEIN